Pharmaceuticals

Our specialist team are adept in dealing with the many ethical and regulatory challenges which are unique to the field, as well as navigating the constantly evolving legal landscape.

Pharmaceutical IP protection

In an ever-evolving industry, pharmacology advancements are not just innovations, they transform lives. With over 50 years of experience of working in in-house intellectual property departments for various pharmaceutical companies, our team has a considerable depth of expertise in technical areas ranging from small molecules to biologics.

Medical capsules in a blister pack, mainly red and white, on a dark surface with reflections and a clear plastic cover at the top.

Our expertise in pharmaceuticals

We utilise our extensive experience in this industry to provide a client-focused service, working with our clients to provide proactive, pragmatic and strategic advice across our full range of services taking into account the key commercial drivers behind each project.

Murgitroyd is well-placed to handle cross-border patent prosecution work for clients in the software, electronics, mechanical engineering, chemistry and life sciences sectors.

Legal 500

Congratulations to our Pharmaceuticals Team for their Gold Award

Financial Times European Leading Patent Law Firms - 2019, 2022, 2023, 2024 & 2025

A white logo for "The Legal 500" with elegant uppercase text and decorative lines on a black background.

Featured insight

Financial Times 2026

Murgitroyd among eight firms to achieve gold across all categories in Financial Times ranking

Read article
  1. Read article

    EPO guidelines for examination: 2026 amendments & updates

  2. Read article

    Obtaining a patent: what makes an invention patentable?

  3. Read article

    Costs of applying for & maintaining a UK patent: a quick guide

  4. Read article

    Murgitroyd’s Helsinki Office Celebrates 15 Years

  5. Read article

    Patentability of AI inventions in Europe: Life Sciences, Chemical and Biotechnology inventions

  6. Read article

    Supplementary Protection Certificates (SPCs): What You Need to Know About the 2025 Changes

  7. Read article

    Applications of Generative AI in Drugs Development and Materials Discovery: IP Considerations

  8. Read article

    Retroactive Santen Rocks the SPC Landscape: Key Takeaways for Pharmaceutical Companies

  9. Read article

    Clouds on the horizon – AI in treating diseases

  10. Read article

    Merck v Mylan — can a presumption of invalidity be a defence for infringement?

  11. Read article

    Compulsory licences in times of crisis

All insights

Discuss your IP needs with our pharma team

Protect breakthroughs in pharmaceuticals from drug formulation to clinical methods. Our IP team ensures your advancements are safeguarded.

+44 [0] 141 307 8400info@murgitroyd.com
Fields Group
Full name
Location
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.